Table 11.
Cox regression hazard model for mortality in optimally debulked cases.
| Factor(s) | HR 1 | 95% CI 2 | p-Value |
|---|---|---|---|
| FIGO stage: IIIA1 | 1 # | ||
| IIIA2 | 3.549 | 0.337–37.387 | 0.299 |
| IIIB | 2.097 | 0.313–14.052 | 0.445 |
| IIIC | 4.369 | 0.895–22.127 | 0.076 |
| IVA | 0.000 | 0.000 | 0.993 |
| IVB | 9.552 | 1.147–79.550 | 0.037 * |
| Cell types: serous | 1 # | ||
| Mucinous | 5.663 | 0.886–36.173 | 0.067 |
| Clear cell | 7.694 | 2.266–26.124 | 0.001 * |
| Endometrioid | 13.156 | 1.286–134.542 | 0.030 * |
| Mixed type | 0.512 | 0.080–3.277 | 0.480 |
| Lymph nodes metastases: No lymph nodes dissection or unknown | 1 # | ||
| Positive of metastases (pathology proof) | 0.226 | 0.073–0.704 | 0.010 * |
| Negative of metastases (pathology proof) | 0.052 | 0.008–0.348 | 0.002 * |
| Adjuvant chemotherapy: GOG-158 | 1 # | ||
| GOG-172 | 0.233 | 0.057–0.951 | 0.042 * |
| JGOG-3016 | 2.198 | 0.243–19.884 | 0.483 |
| ICON-8 | 14.267 | 0.836–243.549 | 0.066 |
| GOG-218/ICON-7 | 0.000 | 0.000 | 0.985 |
1 HR: Hazard ratio. 2 CI: confidence interval. # Reference item. * p < 0.05.